Neurodevelopmental and mental disorders in children with type I and presymptomatic spinal muscular atrophy
Mercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T. & Finkel, R. S. Spinal muscular atrophy. Nat. Rev. Dis. Primers. 8, 52. (2022).
Google Scholar
Dubowitz, V. Chaos in classification of the spinal muscular atrophies of childhood. Neuromuscul. Disord. 1, 77–80. (1991).
Google Scholar
Al-Zaidy, S. et al. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr. Pulmonol. 54, 179–185. (2019).
Google Scholar
Pane, M. et al. Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data. Ann. Neurol. 86, 443–451. (2019).
Google Scholar
Bitetti, I., Manna, M. R., Stella, R. & Varone, A. Motor and neurocognitive profiles of children with symptomatic spinal muscular atrophy type 1 with two copies of SMN2 before and after treatment: A longitudinal observational study. Front. Neurol. 15, 1326528. (2024).
Google Scholar
Buchignani, B. et al. Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: A cohort study. Arch. Dis. Child 109, 395–401. (2024).
Google Scholar
Tosi, M. et al. Neurocognitive profile of a cohort of SMA type 1 pediatric patients and emotional aspects, resilience and coping strategies of their caregivers. Eur. J. Paediatr. Neurol. 43, 36–43. (2023).
Google Scholar
Pechmann, A. et al. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy. Brain 146, 668–677. (2023).
Google Scholar
Darras, B. T. et al. Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls. N. Engl. J. Med. 385, 427–435. (2021).
Google Scholar
Al-Zaidy, S. A. et al. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative study with a prospective natural history cohort. J. Neuromuscul. Dis. 6, 307–317. (2019).
Google Scholar
Erdos, J. & Wild, C. Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic review of real-world study data. Eur. J. Paediatr. Neurol. 39, 1–10. (2022).
Google Scholar
Masson, R., Brusa, C., Scoto, M. & Baranello, G. Brain, cognition, and language development in spinal muscular atrophy type 1: A scoping review. Dev. Med. Child Neurol. 63, 527–536. (2021).
Google Scholar
Lipnick, S. L. et al. Systemic nature of spinal muscular atrophy revealed by studying insurance claims. PLoS ONE 14, e0213680. (2019).
Google Scholar
Finkel, R. S. et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul. Disord. (2017).
Google Scholar
Mercuri, E. et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul. Disord. (2017).
Google Scholar
Salmin, F. et al. Resolution of skin necrosis after nusinersen treatment in an infant with spinal muscular atrophy. Muscle Nerve 59, E42–E44. (2019).
Google Scholar
Oskoui, M. et al. The changing natural history of spinal muscular atrophy type 1. Neurology 69, 1931–1936. (2007).
Google Scholar
Battaglia, G., Princivalle, A., Forti, F., Lizier, C. & Zeviani, M. Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum. Mol. Genet. 6, 1961–1971. (1997).
Google Scholar
Tizzano, E. F., Cabot, C. & Baiget, M. Cell-specific survival motor neuron gene expression during human development of the central nervous system: Implications for the pathogenesis of spinal muscular atrophy. Am. J. Pathol. 153, 355–361. (1998).
Google Scholar
Devriendt, K. et al. Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann. Neurol. 40, 731–738. (1996).
Google Scholar
Harding, B. N. et al. Spectrum of neuropathophysiology in spinal muscular atrophy type I. J. Neuropathol. Exp. Neurol. 74, 15–24. (2015).
Google Scholar
Araki, S. et al. Neuropathological analysis in spinal muscular atrophy type II. Acta. Neuropathol. 106, 441–448. (2003).
Google Scholar
Ito, Y. et al. Thalamic lesions in a long-surviving child with spinal muscular atrophy type I: MRI and EEG findings. Brain Dev. 26, 53–56. (2004).
Google Scholar
Mendonca, R. H. et al. Severe brain involvement in 5q spinal muscular atrophy type 0. Ann. Neurol. 86, 458–462. (2019).
Google Scholar
Maeda, K. et al. Global central nervous system atrophy in spinal muscular atrophy type 0. Ann. Neurol. 86, 801–802. (2019).
Google Scholar
Baranello, G. & Neurodevelopment in, S. M. A. W. G. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy. Eur. J. Paediatr. Neurol. 48, 67–68. (2024).
Alıcı, N. et al. P213 Beneath the iceberg: spinal muscular atrophy (SMA) and autistic spectrum disorder. Neuromuscul. Disord. 33, S88. (2023).
Google Scholar
Abdul Hamid, O. et al. Rate of autism or cognitive delay in spinal muscular atrophy; A single center 1 Year experience. Muscular Dystrophy Association Clinical and Scientific Conference. Poster Number: T390. (2025).
Polido, G. J. et al. Cognitive performance of children with spinal muscular atrophy: A systematic review. Dement Neuropsychol. 13, 436–443. (2019).
Google Scholar
Giannotta, G., Ruggiero, M., De Rinaldis, M. & Trabacca, A. Exploring variability in cognitive functioning in patients with spinal muscular atrophy: A scoping review. Neurol. Sci. 45, 3699–3710. (2024).
Google Scholar
Diagnostic and statistical manual of mental disorders: DSM-5™. 5th edn. (American Psychiatric Publishing, a division of American Psychiatric Association, 2013).
International classification of diseases. 11th revision. (World Health Organization, 2018).
Yu, Y., Ozonoff, S. & Miller, M. Assessment of autism spectrum disorder. Assessment 31, 24–41. (2024).
Google Scholar
Greene, R. K., Vasile, I., Bradbury, K. R., Olsen, A. & Duvall, S. W. Autism diagnostic observation schedule (ADOS-2) elevations in a clinical sample of children and adolescents who do not have autism: Phenotypic profiles of false positives. Clin. Neuropsychol. 36, 943–959. (2022).
Google Scholar
Colombi, C., Fish, A. & Ghaziuddin, M. Utility of the ADOS-2 in children with psychiatric disorders. Eur. Child Adolesc. Psychiatry 29, 989–992. (2020).
Google Scholar
Maddox, B. B. et al. The accuracy of the ADOS-2 in identifying autism among adults with complex psychiatric conditions. J. Autism. Dev. Disord. 47, 2703–2709. (2017).
Google Scholar
Colombo, P. et al. Assessing mental health in boys with Duchenne muscular dystrophy: Emotional, behavioural and neurodevelopmental profile in an Italian clinical sample. Eur. J. Paediatr. Neurol. 21, 639–647. (2017).
Google Scholar
Simone, M. et al. Autism spectrum disorder and Duchenne muscular dystrophy: A clinical case on the potential role of the dystrophin in autism neurobiology. J. Clin. Med. (2021).
Google Scholar
Parravicini, S., Quaranta, C. A., Dainesi, M. I. & Berardinelli, A. The hidden face of Duchenne (neuro) muscular dystrophy. Preliminary evidence of social cognition impairment as a feature of the neuropsychological phenotype of DMD. Front. Psychol. 15, 1504174. (2024).
Google Scholar
Passos-Bueno, M. R., Costa, C. I. S. & Zatz, M. Dystrophin genetic variants and autism. Discov. Ment. Health 2, 4. (2022).
Google Scholar
Ekström, A., Lindeblad, G. & Sofou, K. P. 25A longitudinal study of autism spectrum disorders in children, adolescents and young adults with congenital and childhood myotonic dystrophy type 1. Neuromusc. Disord. 29, S48–S49. (2019).
Google Scholar
Wechsler, D. Wechsler Intelligence Scale for Children. Psychological Corporation. (1949)
Farmer, C. in Encyclopedia of Autism Spectrum Disorders (ed Fred R. Volkmar) 1732–1735 (Springer, 2013).
Raven, J. The raven progressive matrices tests: Their theoretical basis and measurement model. Uses and Abuses of Intelligence: Studies Advancing Spearman and Raven’s Quest for Non-arbitrary Metrics (2008).
Luiz, D. M., Foxcroft, C. D. & Stewart, R. The construct validity of the Griffiths scales of mental development. Child Care Health Dev. 27, 73–83. (2001).
Google Scholar
Lennon, E. M., Gardner, J. M., Karmel, B. Z. & Flory, M. J. in Encyclopedia of Infant and Early Childhood Development (eds Haith, M. M. & Benson, J. B.) 145–156 (Academic Press, 2008).
Esler, A. N. et al. The autism diagnostic observation schedule, toddler module: Standardized severity scores. J. Autism. Dev. Disord. 45, 2704–2720. (2015).
Google Scholar
Kuban, K. C. et al. An algorithm for identifying and classifying cerebral palsy in young children. J. Pediatr. 153, 466–472. (2008).
Google Scholar
Bal, V. H. et al. The adapted ADOS: A new module set for the assessment of minimally verbal adolescents and adults. J. Autism. Dev. Disord. 50, 719–729. (2020).
Google Scholar
Cordis, C. E. E. Evaluation of Autism SpEctrum Disorder in children with Cerebral Palsy (EASED-CP, 2022).
Russell, G., Rodgers, L. R. & Ford, T. The strengths and difficulties questionnaire as a predictor of parent-reported diagnosis of autism spectrum disorder and attention deficit hyperactivity disorder. PLoS ONE 8, e80247. (2013).
Google Scholar
Grasso, M., Lazzaro, G., Demaria, F., Menghini, D. & Vicari, S. The strengths and difficulties questionnaire as a valuable screening tool for identifying core symptoms and behavioural and emotional problems in children with neuropsychiatric disorders. Int. J. Environ. Res. Publ. Health. (2022).
Google Scholar
Janssens, A. & Deboutte, D. Screening for psychopathology in child welfare: The strengths and difficulties questionnaire (SDQ) compared with the Achenbach system of empirically based assessment (ASEBA). Eur. Child Adolesc. Psychiatry 18, 691–700. (2009).
Google Scholar
Global Burden of Disease (GBD) network. GBD study. (Website, 2021).
World Health, O. Depression and other common mental disorders: global health estimates. (World Health Organization, 2017).
Lin, X., He, T., Heath, M., Chi, P. & Hinshaw, S. A systematic review of multiple family factors associated with oppositional defiant disorder. Int. J. Environ. Res. Publ. Health (2022).
Google Scholar
Delamater, A. M., Guzman, A. & Aparicio, K. Mental health issues in children and adolescents with chronic illness. Int. J. Human Rights Healthc. 10, 163–173. (2017).
Google Scholar
Landfeldt, E. et al. Caregiver burden of spinal muscular atrophy: A systematic review. Pharmacoeconomics 41, 275–293. (2023).
Google Scholar
Du, L., Dong, H., Miao, C., Jia, F. & Shan, L. Analysis of scores of symptom checklist 90 (SCL-90) questionnaire of 182 parents of children with spinal muscular atrophy: A cross-sectional study. Transl. Pediatr. 11, 1776–1786. (2022).
Google Scholar
Kaku, S. M. et al. Social experiential deprivation in autism spectrum disorders: A possible prognostic factor?. Asian J. Psychiatr. 26, 44–45. (2017).
Google Scholar
Finkel, R., Bertini, E., Muntoni, F., Mercuri, E. & Group, E. S. W. S. 209th ENMC international workshop: Outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands. Neuromuscul. Disord. 25, 593–602. (2015)
Istituto Nazionale di Statistica. Le misure della vulnerabilità: un’applicazione a diversi ambiti terrioriali. (2020).
Purpura, G. & Coratti, G. Neuro and psychomotor therapist of developmental age professional in Italy: An anomaly or an opportunity?. Archiv. Rehabil. Res. Clin. Trans. 6, 100372. (2024).
Google Scholar
Kaat, A. & Lecavalier, L. in Encyclopedia of Autism Spectrum Disorders (ed Volkmar, F. R.) 590–593 (Springer, 2013).
Goodman, R. The strengths and difficulties questionnaire: A research note. J. Child Psychol. Psychiatr. 38, 581–586. (1997).
Google Scholar
Snow, A. in Encyclopedia of Autism Spectrum Disorders (eds Volkmar, F. R.) 2893–2895 (Springer, 2013).
Dunn, W. Sensory Profile: User’s Manual. xiv, 146: illustrations; 28 cm (Psychological Corp., 1999).
Scattoni, M. L. et al. Autism spectrum disorder prevalence in Italy: A nationwide study promoted by the Ministry of Health. Child Adolesc Psychiatry Ment. Health 17, 125. (2023).
Google Scholar
Coulehan, K. & Baron, I. S. in Encyclopedia of the Neurological Sciences (Second Edition) (eds Aminoff, M. A. & Daroff, R. B.) 528–531 (Academic Press, 2014).
Masi, G. et al. An exploratory study of emotional dysregulation dimensions in youth with attention deficit hyperactivity disorder and/or bipolar spectrum disorders. Front Psychiatry 12, 619037. (2021).
Google Scholar
Paulus, F. W., Ohmann, S., Mohler, E., Plener, P. & Popow, C. Emotional dysregulation in children and adolescents with psychiatric disorders. A narrative review. Front Psychiatry 12, 628252. (2021).
Google Scholar
Marques, S., Correia-de-Sa, T., Guardiano, M., Sampaio-Maia, B. & Ferreira-Gomes, J. Emotion dysregulation and depressive symptoms mediate the association between inhibitory control difficulties and aggressive behaviour in children with ADHD. Front Psychiatry 15, 1329401. (2024).
Google Scholar
Brown, M. A. et al. Understanding emotion dysregulation from infancy to toddlerhood with a multilevel perspective: The buffering effect of maternal sensitivity. Dev. Psychopathol. (2024).
Google Scholar
Saccaro, L. F., Giff, A., De Rossi, M. M. & Piguet, C. Interventions targeting emotion regulation: A systematic umbrella review. J. Psychiatr. Res. 174, 263–274. (2024).
Google Scholar
Tronu, D., Istat. Le misure della vulnerabilità: un’applicazione a diversi ambiti territoriali. Istat. (2020).
link
